Bio-Rad Laboratories, Inc. (BIO)
387.93
-2.01
(-0.52%)
USD |
NYSE |
Aug 28, 16:00
387.93
0.00 (0.00%)
After-Hours: 20:00
Bio-Rad Laboratories Cash from Operations (Quarterly) : 98.70M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 98.70M |
| March 31, 2026 | 108.10M |
| December 31, 2025 | 164.90M |
| September 30, 2025 | 120.90M |
| June 30, 2025 | 116.50M |
| March 31, 2025 | 129.90M |
| December 31, 2024 | 124.17M |
| September 30, 2024 | 163.61M |
| June 30, 2024 | 97.65M |
| March 31, 2024 | 69.18M |
| December 31, 2023 | 81.05M |
| September 30, 2023 | -293.92M |
| June 30, 2023 | 475.85M |
| March 31, 2023 | 111.96M |
| December 31, 2022 | 1.321B |
| September 30, 2022 | -1.350B |
| June 30, 2022 | 386.69M |
| March 31, 2022 | 1.078B |
| December 31, 2021 | -914.03M |
| September 30, 2021 | 230.36M |
| June 30, 2021 | 154.62M |
| March 31, 2021 | 113.61M |
| December 31, 2020 | 1.075B |
| September 30, 2020 | -217.04M |
| June 30, 2020 | -173.48M |
| Date | Value |
|---|---|
| March 31, 2020 | -108.99M |
| December 31, 2019 | 159.80M |
| September 30, 2019 | 99.75M |
| June 30, 2019 | 155.40M |
| March 31, 2019 | 42.94M |
| December 31, 2018 | 105.01M |
| September 30, 2018 | 62.28M |
| June 30, 2018 | 77.86M |
| March 31, 2018 | 40.35M |
| December 31, 2017 | 69.36M |
| September 30, 2017 | 28.48M |
| June 30, 2017 | 62.50M |
| March 31, 2017 | -56.20M |
| December 31, 2016 | 95.12M |
| September 30, 2016 | 51.61M |
| June 30, 2016 | 77.16M |
| March 31, 2016 | -7.448M |
| December 31, 2015 | 35.95M |
| September 30, 2015 | 82.28M |
| June 30, 2015 | 38.53M |
| March 31, 2015 | 29.45M |
| December 31, 2014 | 40.74M |
| September 30, 2014 | 82.75M |
| June 30, 2014 | 80.90M |
| March 31, 2014 | 68.92M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | 2.125B |
| Agilent Technologies, Inc. | 519.00M |
| Danaher Corp. | 1.534B |
| Illumina, Inc. | 201.00M |
| Revvity, Inc. | 191.94M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -66.70M |
| Cash from Financing (Quarterly) | -27.60M |
| Free Cash Flow | 353.10M |
| Free Cash Flow Per Share (Quarterly) | 2.488 |
| Free Cash Flow to Equity (Quarterly) | 74.50M |
| Free Cash Flow to Firm (Quarterly) | 74.99M |
| Free Cash Flow Yield | 3.38% |